PubMed · 1986 · 46 citations · 0 references
MedicinePharmacologyPharmacotherapyCardiovascular PharmacotherapyNeuropharmacologyPsychopharmacologyAntidepressant PharmacologyAntidepressant TherapyBlood Pressure ManagementCardiac MedicationsCardiovascular PharmacodynamicsCardiovascular PharmacologyCardiac Conduction AbnormalitiesHeart RateHemodynamic Drug EffectsMonoamine Oxidase InhibitionMonoamine Oxidase InhibitorsPharmacodynamics Of Cardiovascular DrugsTricyclic Antidepressant Therapy
The cardiovascular effects of monoamine oxidase inhibitors (MAOIs) are contrasted with those of the tricyclic antidepressants (TCAs). At therapeutic doses, MAOIs lower supine blood pressure and increase the postural fall in blood pressure, whereas TCAs have only the latter effect. MAOIs have little effect on heart rate and do not prolong cardiac conduction; TCAs increase heart rate and prolong cardiac conduction. Neither class of drugs appears to impair cardiac mechanical functioning. For patients with certain cardiac problems, MAOIs may have an advantage over TCAs.